{"document": {"publication": "Tag My News", "full_text": "oxigene inc said u.s. health regulators indicated that its experimental thyroid cancer drug may warrant further development, cheering investors a month after the company stopped enrollment in a drug trial.", "title": "fda revives oxigene's thyroid cancer drug hopes, shares surge", "line_count": 1, "filename": "8083", "publication_date": "21-03-2011 17:55:40", "lines_and_colors": [["oxigene inc said u.s. health regulators indicated that its experimental thyroid cancer drug may warrant further development, cheering investors a month after the company stopped enrollment in a drug trial.", {}]]}}